LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

Inicio・Lista de Acciones・Pfizer

Pfizer

Cerrado

SectorSanidad

25.31 -1.67

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

25.24

Máximo

25.82

Métricas clave
By Trading Economics
Ingresos	4.3B 2.7B
Ventas	-3.1B 14B
P/B Media del Sector	19.702 51.415
BPA	0.75
Rentabilidad por dividendo	6.7
Margen de beneficios	18.656
Empleados	75,000
EBITDA	4.5B 5.2B

Recomendaciones
By TipRanks
Recomendaciones	Neutral
Estimación a 12 Meses	+13.28% upside

Dividendos
By Dow Jones
Rentabilidad por dividendo Media del Sector	6.70% 2.34%
Próximas Ganancias	4 ago 2026
Fecha Próximo Dividendo	12 jun 2026
Próxima Fecha de Ex Dividendo	24 jul 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	-2.5B 147B
Apertura anterior	26.98
Cierre anterior	25.31

Noticias sobre sentimiento de mercado

By Acuity

47%

53%

147 / 345 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Bullish Evidence

22.855 / 23.85 Soporte y Resistencia

Pfizer Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

5 may 2026, 11:31 UTC

Ganancias

Pfizer 1Q Revenue Rises But Profit Falls Amid Boosted R&D Spending

5 may 2026, 18:12 UTC

Ganancias

BioNTech to Slash 22% of Workforce as Losses Widen. The Stock Falls. -- Barrons.com

5 may 2026, 13:54 UTC

Ganancias

BioNTech to Slash 25% of Workforce as Losses Widen. The Stock Falls. -- Barrons.com

5 may 2026, 12:35 UTC

Ganancias

Pfizer Posts Better-Than-Expected Revenue, Profit -- WSJ

5 may 2026, 11:06 UTC

Ganancias

Pfizer Stock Edges Higher as Earnings and Revenue Beat Estimates -- Barrons.com

5 may 2026, 10:47 UTC

Ganancias

Pfizer: Current Financial Guidance Doesn't Anticipate Any Stock Buybacks in 2026 >PFE

5 may 2026, 10:47 UTC

Ganancias

Pfizer Still Sees 2026 Adjusted R&D Expenses $10.5B-$11.5B >PFE

5 may 2026, 10:46 UTC

Ganancias

Pfizer 1Q Revenue of Launched, Acquired Products Rose 22% Operationally >PFE

5 may 2026, 10:46 UTC

Ganancias

Pfizer 1Q Revenue Rose 7% Operationally Excluding Contributions From Comirnaty, Paxlovid >PFE

5 may 2026, 10:45 UTC

Ganancias

Pfizer Reaffirms 2026 Guidance >PFE

5 may 2026, 10:45 UTC

Ganancias

Pfizer Sees FY Rev $59.5B-$62.5B >PFE

5 may 2026, 10:45 UTC

Ganancias

Pfizer Sees FY Adj EPS $2.80-Adj EPS $3.00 >PFE

5 may 2026, 10:45 UTC

Ganancias

Pfizer 1Q Rev $14.5B >PFE

5 may 2026, 10:45 UTC

Ganancias

Pfizer 1Q EPS 47c >PFE

5 may 2026, 10:45 UTC

Ganancias

Pfizer 1Q Net $2.69B >PFE

5 may 2026, 10:45 UTC

Ganancias

Pfizer 1Q Adj EPS 75c >PFE

5 may 2026, 10:36 UTC

Acciones populares

Stocks to Watch: Palantir, HSBC, Intel, AMD -- WSJ

23 abr 2026, 21:48 UTC

Adquisiciones, fusiones, absorciones

Regeneron Shares Up on Trump Drug Pricing Deal -- Barrons.com

1 abr 2026, 20:07 UTC

Adquisiciones, fusiones, absorciones

Why 2026 Is Biotech's Comeback Year -- Barrons.com

11 mar 2026, 11:02 UTC

Charlas de Mercado

Sanofi, Regeneron's Eczema Drug Might Face Competition From Pfizer -- Market Talk

10 mar 2026, 12:50 UTC

Ganancias

BioNTech Stock Plunges 17% After Earnings. Why the Drugmaker Faces a Perfect Storm. -- Barrons.com

10 mar 2026, 11:18 UTC

Ganancias

BioNTech Plunges as Drugmaker Swings to a Loss. More Than Earnings Are Weighing on the Stock. -- Barrons.com

9 mar 2026, 09:43 UTC

Acciones populares

Stocks to Watch Monday: Lamb Weston, Carnival, Pfizer -- WSJ

10 feb 2026, 21:51 UTC

Ganancias

Gilead Earnings Surprise. Why The Stock Is Tumbling Anyway. -- Barrons.com

10 feb 2026, 21:17 UTC

Ganancias

Gilead Earnings Surprise. Why The Stock Is Tumbling Anyway. -- Barrons.com

3 feb 2026, 21:36 UTC

Ganancias

These Stocks Are Today's Movers: Palantir, Pfizer, AMD, PayPal, Novo Nordisk, PepsiCo, Merck, and More -- Barrons.com

3 feb 2026, 19:56 UTC

Ganancias

Pfizer Stock Falls After Solid Earnings. What's Troubling Wall Street. -- Barrons.com

3 feb 2026, 19:46 UTC

Ganancias

These Stocks Are Today's Movers: Palantir, Pfizer, AMD, PayPal, Novo Nordisk, PepsiCo, Merck, and More -- Barrons.com

3 feb 2026, 17:35 UTC

Ganancias

Pfizer Stock Falls After Solid Earnings. What's Troubling Wall Street. -- Barrons.com

3 feb 2026, 17:30 UTC

Ganancias

These Stocks Are Today's Movers: Palantir, PayPal, Novo Nordisk, Pfizer, Merck, AMD, Gartner, and More -- Barrons.com

Comparación entre iguales

Cambio de precio

Pfizer previsión

Precio Objetivo

By TipRanks

13.28% repunte

Estimación a 12 Meses

Media 29.17 USD 13.28%

Máximo 36 USD

Mínimo 25 USD

De acuerdo con 22 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Pfizer Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

22 ratings

Comprar

Mantener

Vender

De acuerdo con 22 analistas que ofrecen calificaciones bursátiles a para Pfizer Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

22.855 / 23.85Soporte y Resistencia

Bullish events outweigh bearish events.

Bearish events outweigh bullish events.

All events are bearish.

Sentimiento

By Acuity

147 / 345 Clasificación en Sanidad

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as has strategic clinical collaboration with Acepodia Inc. for the development of antibody-cell conjugation-based cell therapies in autoimmune diseases. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.